<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/rapp" ></link>
<id>urn:uuid:cc4b7e67-26c3-2fa0-15f4-81882c7a739e</id>
<updated>2026-06-16T03:35:35-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>RAPP: THIRD ROCK VENTURES V L P (BO) Sold (AS) 18,572 Shares of RAPPORT THERAPEUTICS INC for $40.05 on 5/26</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6413884" ></link>
<id>urn:uuid:496403b7-f953-c0f7-0bd3-a7bc39d298d7</id>
<updated>2026-05-28T16:15:04-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: THIRD ROCK VENTURES V L P (BO) Sold (AS) 133,618 Shares of RAPPORT THERAPEUTICS INC for $40.24 on 5/11</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6402213" ></link>
<id>urn:uuid:266e87a0-fd0f-6235-da58-414ff0b81171</id>
<updated>2026-05-13T19:06:16-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: THIRD ROCK VENTURES V L P (BO) Sold (AS) 276,513 Shares of RAPPORT THERAPEUTICS INC for $40.12-$40.31 on 5/7-5/8</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6399990" ></link>
<id>urn:uuid:d064edfb-00f8-1f68-bcaa-178452d9c55a</id>
<updated>2026-05-11T17:07:03-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: THIRD ROCK VENTURES V L P (BO) Sold (AS) 426,005 Shares of RAPPORT THERAPEUTICS INC for $40.32 on 4/17</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6389200" ></link>
<id>urn:uuid:77c56a93-4df6-8af4-54eb-58dcc8bdf1d8</id>
<updated>2026-04-21T19:36:04-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: YELESWARAM KRISHNASWAMY (O) Sold (AS) 20,225 Shares of RAPPORT THERAPEUTICS INC for $39.99 on 4/17</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6389054" ></link>
<id>urn:uuid:6ea563e2-885b-5a7b-1305-fb10bc8b4a15</id>
<updated>2026-04-21T16:55:07-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: YELESWARAM KRISHNASWAMY (O) Sold (AS) 19,865 Shares of RAPPORT THERAPEUTICS INC for $34.97-$35.08 on 4/10-4/14</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6386046" ></link>
<id>urn:uuid:c531a141-5573-5895-f9c9-8aaedb2a43b3</id>
<updated>2026-04-14T16:13:40-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: YELESWARAM KRISHNASWAMY (O) Sold (AS) 360 Shares of RAPPORT THERAPEUTICS INC for $34.90 on 4/8</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6384265" ></link>
<id>urn:uuid:5d441f19-763c-6f21-53f0-e48f823f7699</id>
<updated>2026-04-09T16:30:27-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: GAULT CHERYL (COO) Sold (AS) 10k Shares of RAPPORT THERAPEUTICS INC for $28.04-$28.55 on 3/30</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6376645" ></link>
<id>urn:uuid:53d0793a-5cf2-e71a-7a01-5fac4c9d116f</id>
<updated>2026-03-31T16:27:37-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: YELESWARAM KRISHNASWAMY (O) Sold (AS) 10,115 Shares of RAPPORT THERAPEUTICS INC for $29.99 on 3/25</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6374278" ></link>
<id>urn:uuid:6d2106aa-c0f4-495f-cd83-f7de91695447</id>
<updated>2026-03-26T16:41:16-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
<entry>
<title>RAPP: GAULT CHERYL (COO) Sold (S) 2,014 Shares of RAPPORT THERAPEUTICS INC for $28.93 on 3/5</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6355879" ></link>
<id>urn:uuid:efb7460c-c53a-0bb0-4d04-98a5a0286a19</id>
<updated>2026-03-09T16:07:30-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $38.40. Mkt Cap:1.8B. 10D Vol: 322,110]]></summary>
</entry>
</feed>